Palestinians say vaccines could come in March, accuse Israel of shirking duty to supply them
By Nidal al-Mughrabi GAZA (Reuters) - The Palestinian Authority said on Sunday it expects to receive its first COVID-19 vaccine doses in March under a deal with drugmaker AstraZeneca, and accused Israel of shirking a duty to ensure vaccines are available in occupied territory. While Israel has already become the world leader in vaccinations per capita, Palestinians in the Israeli-occupied West Bank and the Gaza Strip have yet to secure their first supplies
By Nidal al-Mughrabi
GAZA (Reuters) - The Palestinian Authority said on Sunday it expects to receive its first COVID-19 vaccine doses in March under a deal with drugmaker AstraZeneca, and accused Israel of shirking a duty to ensure vaccines are available in occupied territory.
While Israel has already become the world leader in vaccinations per capita, Palestinians in the Israeli-occupied West Bank and the Gaza Strip have yet to secure their first supplies.
Yasser Bozyeh, the Palestinian general director of public health, told Reuters that in addition to reaching an agreement in principle with AstraZeneca, the Palestinians had also sought supplies from Moderna, Johnson & Johnson and Russia, which has developed the Sputnik V vaccine.
Supplies would also come through a World Health Organization vaccine programme for poor and middle income countries.
There was no immediate response from AstraZeneca to an emailed request from Reuters for comment.
The Palestinian Foreign Ministry said in a statement Israel had been "ignoring its duties as an occupation power and committing racial discrimination against the Palestinian people, depriving them of their right to healthcare."
"The search by the Palestinian leadership to secure the vaccines from various sources doesn't exempt Israel from its responsibilities towards the Palestinian people in providing the vaccines," it said.
Under interim peace accords with Israel, the Palestinian Authority exercises limited self-rule in the West Bank. Hamas Islamists run the Gaza Strip.
Israel's vaccination programme covers the country's Arab citizens and Palestinian residents of East Jerusalem.
On the West Bank, it has given vaccines to Israeli settlers, but not to Palestinian residents, who receive health services from the Palestinian Authority.
Human rights groups including Amnesty International say Israel has a legal obligation to provide vaccines for Palestinians under occupation. Israeli officials say they could share vaccines with the Palestinians once Israel's own needs are met.
A WHO official said on Sunday the organisation had held "informal discussions" with Israel over allocating some supplies to the Palestinians to inoculate health workers. The official, Gerald Rockenschaub, head of the WHO office in the Palestinian territories, said Israel indicated it would explore the option.
(Reporting by Nidal al-Mughrabi in Gaza and Ali Sawafta in Ramallah; Writing by Jeffrey Heller; Editing by Peter Graff)
This story has not been edited by Firstpost staff and is generated by auto-feed.
Find latest and upcoming tech gadgets online on Tech2 Gadgets. Get technology news, gadgets reviews & ratings. Popular gadgets including laptop, tablet and mobile specifications, features, prices, comparison.
By Steve Holland and Andrea Shalal JOINT BASE ANDREWS, Md./WASHINGTON (Reuters) - U.S. President Donald Trump, facing impeachment on a charge of "incitement of insurrection" on Tuesday disavowed responsibility for his supporters' violent invasion of the U.S. Capitol last week and said his remarks before the siege were appropriate.
PARIS (Reuters) - French carmaker Renault and U.S. hydrogen specialist Plug Power have joined forces to develop hydrogen-powered light commercial vehicles, they said on Tuesday. The companies have signed a memorandum of understanding to launch a France-based 50-50 joint venture by the end of the first half of 2021, targeting more than 30% share of the fuel cell-powered light commercial vehicle market in Europe, their joint statement said
By Yilei Sun and Brenda Goh BEIJING/SHANGHAI (Reuters) - New models will help electric vehicle sales in China zoom this year, after tepid business in a virus-riddled 2020, and analysts predict Tesla's Model Y pricing will emerge as a major disruptor in the world's biggest car market. Tesla Inc, which became the world's most valuable car maker last year, started selling locally made Model Y SUVs in China this month, for almost a tenth less than gasoline-powered luxury cars with similar market positioning. It set the starting price at 339,900 yuan ($52,376), or 10% below official prices of Daimler's Mercedes GLC, BMW's X3 and Audi's Q5L - all locally made gasoline sport utility vehicles (SUVs) with similar size and positioning.